Illumina $ILMN Event: "Something big is coming. And it's small." The MiSeq 100 series. Slightly smaller than the NextSeq 2000.

Medical equipment maker Illumina on Wednesday announced its new series of smaller, low-cost benchtop gene sequencers, a move that will make sequencing accessible to more research and testing labs. reut.rs/3ZUBvd5 reut.rs/3ZUBvd5

Meet the MiSeq i100 Series – the new standard in sequencing simplicity. With 3-step setup, onboard DRAGEN analysis, and same-day results, what will you discover next? bit.ly/3zG9hs7

Edinburgh Genomics staff staying late to hear the exciting Illumina announcements about MiSeq i100! #sequencing #illumina #Genomics #NGS #nextgeneration

i'm monitoring a few genomics chat groups and it's funny but I think the whole genomics community tuned in for that Illumina . congratulations

Hello!

Ready for #ISER2024 ISER in Buenos Aires! UGent Geneeskunde & Gezondheidswetenschappen UGent Wetenschappen RARE-MED will be represented well by Eva D'haene Munevver Burcu Cicekdal Frauke Coppieters Bart Leroy Elfride De Baere More info about our talks and sessions will follow!

#DRAGEN Illumina method fully described & benchmarked out in Nature Biotechnology: nature.com/articles/s4158… Graph genome based detection of SNV, STR, SV, CNV all in 30 min! Improvements in all variants! Huge thanks to Severine Catreux Rami mehio Sairam Behera BCM HGSC #Bioinformatics 1/5

To have a bit fun.. I generated this one.. :) To many more adventures ! 5/5

🔴 The new episode of our posdact "Beating Cancer Belgium" is out! This third episode is discussing on the evolving role of #telemedicine in #cancer care and control. This Sciensano podcast is created by the Belgian 'EBCP' mirror group initiative. 🎧 beatingcancer.be/third-episode-…

bit.ly/3CeF5VV

Christos Vaklavas maps the path of development of novel agents targeting PIK3CA and discusses phase 1 results of RLY-2608, STX-478 and LOXO-783 #SABCS24 OncoAlert

📌“Optimizing outcomes for HER2-expressing breast cancer through novel biomarkers and TKIs” Great discussion by Paolo Tarantino 👏🏻 #SABCS24 #day3 OncoAlert #OncoAlertAF Dana-Farber’s Breast Oncology Center

Accelerating AI adoption to improve Genomic Medicine #NHSGenomics2024

Researchers from the CME UZ Leuven KU Leuven developed a new technique that combines #genetic and #epigenetic analyses. This opens the door to faster diagnosis and more insight into the cause of #rarediseases. Covered in the national news 👇 vrt.be/vrtnws/nl/2025…

Enfortumab vedotin and stereotactic radiation tested before surgery in #MIBC in the STAR-EV trial. Tian Zhang, MD, MHS UT Southwestern Medical Center joins Leslie Ballas Cedars-Sinai to discuss the combination of EV and radiation for cisplatin-ineligible muscle-invasive bladder cancer patients. The study

🧬🤓 A pleasure to attend today to the Belgian Society of Medical Oncology Meeting 2025 Belgian Society of Medical Oncology #BSMO2025 at Brugge #oncology #precisionmedicine #diagnostics #NGS

Meet Shane Liddelow 🍊, a neuroscientist at NYU Langone Health who is using the new Illumina Single Cell 3’ Prep to investigate a challenging target: astrocytes. With the flexibility of our new technology, the team can sequence 2,000 cells just as easily as 200,000—and it allows them

📣 My new paper is online! 🦠 🔥Straight from the oven🔥 9 April 2025 😎 🤓 It's not much, but it's honest work 💅 #HPV #Splicing #alternativesplicing #virus #cervicalcancer PLOS Pathogens IPVS - International Papillomavirus Society Virology Tweets MRC-Uni of Glasgow Centre for Virus Research journals.plos.org/plospathogens/…

📢 Stay in the loop with #EASIGEN-DS newsletter! Our newsletter is launching soon, make sure you receive updates on the project and take a sneak peak of what's coming soon! Subscribe here➡️ eepurl.com/jb3tSY #EASIGEN-DS #ResearchInfrastructure #HorizonEU